StockData
CalciMedica, Inc. logo

CalciMedica, Inc. (CALC) stock

CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$1.17−0.05 (-4.10%)

Close on Nov 18, 2026Market cap $39.95MP/E –Yield –

CalciMedica revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for CalciMedica

CalciMedica has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More CalciMedica figures

See a number that looks wrong?